Kim, J. H., Park, S., Jung, E., Shin, J. W., Kim, Y., Kim, J. Y., . . . Kim, J. S. (2023). A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis.
Citazione stile Chigago Style (17a edizione)Kim, Ji Hyeon, Soeun Park, Eunsun Jung, Jin Woo Shin, Yoon-Jae Kim, Ji Young Kim, Jonathan L. Sessler, Jae Hong Seo, e Jong Seung Kim. A Dual-action Niclosamide-based Prodrug That Targets Cancer Stem Cells and Inhibits TNBC Metastasis. 2023.
Citatione MLA (9a ed.)Kim, Ji Hyeon, et al. A Dual-action Niclosamide-based Prodrug That Targets Cancer Stem Cells and Inhibits TNBC Metastasis. 2023.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.